Sanofi US News

Plaintiffs allege cancer drug Taxotere causes permanent hair loss, sue manufacturer

By Chandra Lye | Jul 15, 2017

The first case in multi-district litigation (MDL) revolving around permanent hair loss from a breast cancer drug has been set for trial in September 2018.

Aventis Pharma et al allegedly failed to warn cancer patients of Taxotere's side effects

By The Louisiana Record | Oct 11, 2016

NEW ORLEANS — A breast cancer patient has filed suit against three drug manufacturing companies for alleged design defect, failure to warn and breach of express warranty.

The Record Network